Marks & Spencer

Cautious stance on the outlook

13/01/22 -"M&S has delivered good Q3 21/22 sales, mainly driven by the strong Christmas trading performance. The Food business maintained solid momentum, and the C&H also experienced positive growth for ..."

PDF page sample
Pages
42
Language
English
Published on
13/01/22
Download
You may also be interested by these reports :
18/07/25
Positive trigger for online pharmacies: The decision of the Federal Bureau of Justice confirms the ECJ ruling
17/07/25
Higher earnings – TP increase to EUR 4.40 – Add confirmed
16/07/25
3Q24/25 with good adj. EBIT progress – FY24/25E EBIT guidance increase
11/07/25
We increase our FY25E-27E projections – New TP of EUR 67

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO